🇺🇸 furosemide infusion in United States

10 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Acute Myocardial Infarction — 1 report (10%)
  2. Asthenia — 1 report (10%)
  3. Cardiac Failure Congestive — 1 report (10%)
  4. Colitis — 1 report (10%)
  5. Drug Interaction — 1 report (10%)
  6. Hypotension — 1 report (10%)
  7. Mental Status Changes — 1 report (10%)
  8. Metabolic Acidosis — 1 report (10%)
  9. Nuclear Magnetic Resonance Imaging Brain Abnormal — 1 report (10%)
  10. Progressive Multifocal Leukoencephalopathy — 1 report (10%)

Source database →

furosemide infusion in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is furosemide infusion approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for furosemide infusion in United States?

Reprieve Cardiovascular, Inc is the originator. The local marketing authorisation holder may differ — check the official source linked above.